Q3 2024 |
673 |
$528M |
+$24.3M |
-$14.4M |
+$9.94M |
DRSK, ACIO, VIGI, JUCY, SPLG
|
13F-HR |
10/8/2024, 09:31 AM |
Q2 2024 |
663 |
$493M |
+$11.8M |
-$5.85M |
+$5.93M |
DRSK, ACIO, JUCY, VIGI, SPLG
|
13F-HR |
7/8/2024, 12:02 PM |
Q1 2024 |
674 |
$482M |
+$59.7M |
-$12.3M |
+$47.3M |
DRSK, ACIO, JUCY, VIGI, SPLG
|
13F-HR |
4/23/2024, 09:52 AM |
Q4 2023 |
683 |
$414M |
+$12.4M |
-$26M |
-$13.5M |
DRSK, JUCY, ACIO, VIGI, OSCV
|
13F-HR |
1/10/2024, 11:56 AM |
Q3 2023 |
680 |
$395M |
+$46.3M |
-$61.9M |
-$15.7M |
DRSK, JUCY, ACIO, VIGI, OSCV
|
13F-HR |
11/13/2023, 09:20 AM |
Q2 2023 |
691 |
$427M |
+$23.5M |
-$12.1M |
+$11.4M |
DRSK, ACIO, JUCY, OSCV, VIGI
|
13F-HR |
7/13/2023, 09:45 AM |
Q1 2023 |
698 |
$406M |
+$38.3M |
-$43.4M |
-$5.1M |
DRSK, ACIO, JUCY, OSCV, VIGI
|
13F-HR |
4/26/2023, 01:48 PM |
Q4 2022 |
784 |
$398M |
+$61.6M |
-$72.7M |
-$11.1M |
DRSK, ACIO, ADME, JUCY, OSCV
|
13F-HR |
2/3/2023, 11:51 AM |
Q3 2022 |
817 |
$387M |
+$19.5M |
-$8.08M |
+$11.4M |
DRSK, ACIO, ADME, OSCV, IDUB
|
13F-HR |
10/11/2022, 02:56 PM |
Q2 2022 |
760 |
$397M |
+$70.3M |
-$43.1M |
+$27.2M |
DRSK, ACIO, ADME, IDUB, OSCV
|
13F-HR |
7/11/2022, 07:01 PM |
Q1 2022 |
699 |
$421M |
+$23.6M |
-$5.92M |
+$17.7M |
DRSK, ACIO, ADME, OSCV, IDUB
|
13F-HR |
4/25/2022, 04:22 PM |
Q4 2021 |
734 |
$421M |
+$21.8M |
-$4.49M |
+$17.3M |
DRSK, ACIO, ADME, OSCV, IDUB
|
13F-HR |
1/20/2022, 02:07 PM |
Q3 2021 |
742 |
$380M |
+$37.9M |
-$18.1M |
+$19.7M |
DRSK, ACIO, ADME, OSCV, IDUB
|
13F-HR |
10/20/2021, 12:09 PM |
Q2 2021 |
734 |
$366M |
+$160M |
-$29.5M |
+$130M |
DRSK, ADME, ACIO, OSCV, IEFA
|
13F-HR |
7/20/2021, 10:34 AM |
Q1 2021 |
730 |
$256M |
+$17.5M |
-$1.17T |
-$1.17T |
DRSK, ACIO, ADME, OSCV, RSP
|
13F-HR |
4/19/2021, 04:32 PM |
Q4 2020 |
704 |
$298M |
+$12M |
-$7.62M |
+$4.34M |
DRSK, ADME, ACIO, AGG, ITOT
|
13F-HR |
2/3/2021, 03:20 PM |
Q3 2020 |
661 |
$272M |
+$36.9M |
-$25.2M |
+$11.7M |
DRSK, ADME, ACIO, AGG, ITOT
|
13F-HR |
11/3/2020, 01:59 PM |
Q2 2020 |
666 |
$256M |
+$19.9M |
-$13.6M |
+$6.3M |
DRSK, ADME, ACIO, AGG, QQQ
|
13F-HR |
7/20/2020, 06:07 PM |
Q1 2020 |
675 |
$220M |
+$48.3M |
-$26.6M |
+$21.7M |
DRSK, ACIO, ADME, AGG, IEFA
|
13F-HR |
4/15/2020, 11:19 AM |
Q4 2019 |
690 |
$235M |
$0 |
$0 |
|
DRSK, ADME, ACIO, ITOT, OSCV
|
13F-HR |
1/29/2020, 02:26 PM |